Emotional experiences of oncologists treating women with metastatic breast cancer (MBC)

被引:0
|
作者
Brufsky, Adam
Mayer, Musa
Dickson, Robyn Bell
Citron, Marc L.
机构
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[2] AdvancedBC Org, New York, NY USA
[3] Harris Poll, New York, NY USA
[4] ProHlth Care Assoc LLP, Lake Success, NY USA
关键词
D O I
10.1200/jco.2015.33.28_suppl.97
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
97
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Bevacizumab as maintenance therapy (mBev) in metastatic breast cancer (MBC).
    Militello, Loredana
    Carli, Paolo
    Di Lauro, Vincenzo
    Spazzapan, Simon
    Scalone, Simona
    Lombardi, Davide
    Tuzi, Alessandro
    Talamini, Renato
    Quitadamo, Daniela
    Turchet, Elisa
    Crivellari, Diana
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [42] A phase II study of vinorelbine (VNR) and letrozole (LTZ) in aged women with metastatic breast cancer (MBC).
    Manga, GP
    Bueno, JMG
    Palombo, H
    Morales, S
    Méndez, M
    Esteban, B
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 65S - 65S
  • [43] Cardiac safety of epirubicin/cyclophosphamide (EC) alone and in combination with herceptin in women with metastatic breast cancer (MBC).
    Thomssen, CH
    Eidtmann, H
    Untch, M
    Meerpohl, HG
    du Bos, A
    Schaller, G
    Kuhn, W
    Jackisch, CH
    Kreienberg, R
    Wallwiener, D
    Weise, W
    Emons, G
    Langer, B
    Lueck, HJ
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S111 - S111
  • [44] Trastuzumab (T) and CNS metastases in women with HER-2 positive metastatic breast cancer (MBC).
    Dawson, SJJ
    Ranieri, NF
    Snyder, RD
    McLachlan, SAA
    Burns, WI
    Newnham, GM
    Francis, PA
    Dowling, AJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 49S - 49S
  • [45] Phase II study of gemcitabine and cisplatin in women with taxane-failed metastatic breast cancer (MBC)
    Wang, T.
    Jiang, Z.
    Song, S.
    Shen, G.
    Zhang, S.
    Wu, S.
    Zeng, M.
    EJC SUPPLEMENTS, 2005, 3 (02): : 127 - 127
  • [46] Efficacy of Fulvestrant in Women with Hormone-Resistant Metastatic Breast Cancer (mBC): A Canadian Province Experience
    Andrahennadi, Samitha
    Sami, Amer
    Haider, Kamal
    Chalchal, Haji Ibraheem
    Le, Duc
    Ahmed, Osama
    Manna, Mita
    El-Gayed, Ali
    Wright, Philip
    Ahmed, Shahid
    CANCERS, 2021, 13 (16)
  • [47] Which bisphosphonates do oncologists prescribe for women with metastatic breast cancer and why? Results of a UK survey
    Fallowfield, Lesley
    Jenkins, Valerie
    Coleman, Robert
    BREAST, 2008, 17 (05): : 459 - 463
  • [48] Patient and Medical Oncologists' Perspectives on Prescribed Lifestyle Intervention-Experiences of Women with Breast Cancer and Providers
    Balneaves, Lynda G.
    Truant, Tracy L. O.
    Van Patten, Cheri
    Kirkham, Amy A.
    Waters, Erin
    Campbell, Kristin L.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 13
  • [49] IMPACT: IMaging PAtients for Cancer drug selecTion - Metastatic breast cancer (MBC)
    Bensch, Frederike
    Brouwers, Adrienne
    Glaudemans, Andor
    de Jong, Johan
    de Vries, Erik
    van de Graaf, Winette
    Boon, Eline
    Oyen, Wim
    de Geus-Oei, Lioe-Fee
    Visser, Eric
    van Helden, Erik
    van Oordt, Willemien Menke-van der Hoeven
    Verheul, Henk
    Hoekstra, Otto
    Janssen, Jim
    Huisman, Marc
    Elias, Sjoerd
    Moons, Carl
    de Vries, Liesbeth
    Schroder, Carolien
    CANCER RESEARCH, 2015, 75
  • [50] Phase II Trial of Vinorelbine and Sorafenib in Metastatic Breast Cancer (MBC)
    Luu, T.
    Frankel, P.
    Chung, C.
    Mortimer, J.
    Hurria, A.
    Somlo, G.
    CANCER RESEARCH, 2010, 70